Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer - Blancas, I.; Olier, C.; Conde, V.; Bayo, J. L.; Herrero, C.; Zarcos-Pedrinaci, I.; Carabantes, F.; Baena-Canada, J. M.; Cruz, J.; Ruiz-Borrego, M.; (Scientific Reports, 2021)